NUVL Nuvalent, Inc.
Price Chart
Executive Summary
Two Nuvalent insiders (CEO and Chief Development Officer) sold a combined ~$3.56M in open-market shares on June 8-9, 2026, alongside derivative exercises. The sales represent only ~0.04% of market cap and are routine option-exercise-related transactions. The dominant event is GSK's $10.6B acquisition of Nuvalent at $124/share, announced June 9, rendering these insider sales immaterial.
Key Financial Metrics
Actionable Insight
The insider cluster is trivial and should not influence trading decisions. Focus on the GSK acquisition: monitor regulatory approval and tender process for Q3 2026 close. The $124/share offer represents a premium to recent trading levels.
Key Facts
- CEO James Porter exercised 60,000 options (30k at $18.93, 30k at $0) and sold 12,495 shares for ~$1.10M on June 8.
- CDO Darlene Noci exercised 20,000 options (10k at $0, 10k at $1.08) and sold 20,000 shares for ~$2.46M on June 9.
- Total open-market sales: ~$3.56M, or 0.037% of Nuvalent's $9.7B market cap.
- GSK announced acquisition of Nuvalent for $124/share in cash on June 9, 2026, valuing equity at $10.6B.
- Insider sales occurred after the deal announcement and are consistent with routine option cash-outs, not informed selling.
Financial Impact
Insider sales of ~$3.56M are negligible relative to the $10.6B acquisition value and $9.7B market cap.
Risk Factors
- Regulatory or antitrust hurdles delaying or blocking the GSK acquisition.
- Shareholder approval or minimum tender condition not met.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NUVL-1781209982276 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Insider Cluster
| $123.40 awaiting T+20 | awaiting T+20 | — | $123.25 (−0.12%) |
|
Jun 10, 2026
2d ago
|
Insider Cluster
| $123.40 awaiting T+20 | awaiting T+20 | — | $123.25 (−0.12%) |
|
Jun 9, 2026
4d ago
|
8-K
| $122.92 awaiting T+20 | awaiting T+20 | — | $123.25 (+0.27%) |
|
May 7, 2026
5w ago
|
8-K
| $102.40 $90.18 | ▼ −11.93% | ▼ −15.07% | $123.25 (+20.36%) |
|
Apr 29, 2026
6w ago
|
Insider Cluster
| $99.10 $107.38 | ▲ +8.36% | ▲ +2.90% | $123.25 (+24.37%) |
|
Apr 7, 2026
9w ago
|
8-K
| $102.25 $102.62 | ▲ +0.36% | ▼ −9.42% | $123.25 (+20.54%) |
|
Apr 6, 2026
9w ago
|
Insider Cluster
| $103.71 $102.62 | ▲ +1.05% | ▲ +10.03% | $123.25 (−18.84%) |
|
Mar 30, 2026
10w ago
|
Insider Cluster
| $96.72 $101.94 | ▼ −5.40% | ▲ +7.20% | $123.25 (−27.43%) |
|
Mar 26, 2026
11w ago
|
Insider Cluster
| $98.06 $104.50 | ▲ +6.57% | ▼ −4.10% | $123.25 (+25.69%) |
|
Mar 25, 2026
11w ago
|
Insider Cluster
| $98.00 $108.02 | ▼ −10.22% | ▼ −2.36% | $123.25 (−25.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access